References

[1] Liptak JM, Dernel WS,

Monett E, Powers B, Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002), J Am Vet Med Assoc. 2004; 225(8):1225-30. DOI: 10.2460/ javma.2004.225.1225.

[2] Selmic LE, Hepatobiliary Neoplasia, Vet Clin North Am Small Anim Pract, 2017; 47(3):725-735. DOI: 10.1016/j. cvsm.2016.11.016. Epub 2017 Jan 5.

[3] Balkman C, Hepatobiliary neoplasia in dogs and cats, Vet Clin North Am Small Anim Pract. 2009; 39(3):617-25.

[4] Magne ML, Withrow SJ, Hepatic neoplasia, Vet Clin North Am Small Anim Pract, 1985; 15(1):243-56.

[5] Thompson MB, Chappell JD, Kunze DJ, et al., Bile acid profile in a dog with cholangiocarcinoma, Vet Pathol. 1989; 26(1):75-8.

[6] https://veteriankey.com/ chemotherapy/, chapter 44: Chemotherapy

[7] Orna K, Kenneth MR, John MG, et al., Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs, J Vet Intern Med. Jan-Feb 2004; 18(1):75-80. doi:10.1892/0891-6640.

[8] Webster CRL, Center SA, Cullen JM, et al., ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs, J Vet Intern Med. 2019; 33(3):1173-1200. Epub 2019 Mar 7.

[9] Patnaik AK, Hurvitz AI, Lieberman PH. Canine hepatic neoplasms: A clinicopathologic study. Vet Pathol. 1980; 17:553-564.

[10] Monnet E, Kudnig S. Alimentary tract, liver, and pancreas. In: Slatter DH, editor. Textbook of Small Animal Surgery. Philadelphia, Pennsylvania: WB Saunders; 1993; 2378-2382.

[11] Liptak JM. Hepatobiliary tumors. In: Withrow SJ, Vail DM, editors. Withrow & MacEwens Small Animal Clinical Oncology. St. Louis, Missouri: Elsevier; 2007; 483-490.

[12] Guan YS, He Q. Liver cancer: Zheng Classification of Qi stagnation and blood stasis. Pharmacology & Pharmacy, 2014, 5, 75-82, http://dx.doi. org/10.4236/ pp.2014.51012

[13] Liptak JM, Dernell WS, Withrow SJ. Liver tumors in cats and dogs.

[14] Guilford WG, Strombeck DR. Hepatic neoplasms. In: Guilford WG, Strombeck DR, Williams DA, editors. Strombecks Small Animal Gastroenterology. 3rd ed. Philadelphia: Pennsylvania: Saunders; 1996. 847-859.

[15] Patnaik AK, Hurvitz AI, Lieberman PH, et al., Canine hepatocellular carcinoma. Vet Pathol. 1981; 18:427-438.

[16] Kosovsky JE, Manfra-Marretta S, Matthiesen Dt, et al., Results of partial hepatectomy in 18 dogs with hepatocellular carcinoma. J Am Vet Med Assoc. 1989; 25:203-206.

[17] Mori T, Ito Y, Kawabe M, et al., Three-dimensional conformal radiation therapy for inoperable massive hepatocellular carcinoma in six dogs, https://doi.org/10.1111/jsap.12352

[18] Dobos GJ, Kirschbaum B, Choi KE, The Western model of integrative oncology: the contribution of Chinese medicine, Chin J Integr Med. 2012; 18(9):643-651. DOI: 10.1007/s11655-012- 1200-1. Epub 2012 Aug 31.

[19] Xie HS, Preast V, Traditional Chinese Veterinary Medicine: Fundamental Principles, Chi Intitute Press; 2nd edition (January 1, 2013), ISBN-10: 1934786411.

[20] Marconato L, Sabattini S, Marisi G, et al., Sorafenib for the treatment of unresectable hepatocellular carcinoma: preliminary toxicity and activity

data in dogs, Cancers 2020; 12:1272; DOI:10.3390/cancers12051272

[21] Leifer CE, Peterson ME, Matus RE, et al. Hypoglycemia associated with nonislet cell tumor in 13 dogs. J Am Vet Med Assoc. 1985; 186:53-55.

[22] Strombeck DR, Krum S, Meyer D, et al. Hypoglycemia and hypoinsulinemia associated with hepatoma in a dog. J Am Vet Med Assoc. 1976; 169:811-812.

[23] Quigley KA, Jackson ML, Haines DM. Hyperlipasemia in 6 dogs with pancreatic or hepatic neoplasia: evidence for tumor lipase production. Vet Clin Pathol. 2001; 30:114-120.

[24] Lowseth LA, Gillett NA, Chang IY, et al. Detection of serum alpha-fetoprotein in dogs with hepatic tumors. J Am Vet Med Assoc. 1991; 199:735-741.

[25] Yamada T, Fujita M, Kitao S, et al.

[26] Hammer AS, Sikkema DA. Hepatobiliary tumors. In: Withrow SJ, MacEwen EG, editors: Small Animal Clinical Oncology, Ed 3, Philadelphia, 2001, WB Saunder.

[27] Chuang CH, Chen CF, Tseng NC, et al. The first attempt of the biokinetic Ga-67 model application to canine liver carcinoma: case-control study via in-vivo gamma camera/8-slice

CT technique. Journal of Mechanics in Medicine and Biology, 2018; 18(7):1840019 https://doi.org/10.1142/ S0219519418400225.

[28] Chen CF, Chuang CH, Tang PC, et al. Biokinetic model development of radioiodine-131 via in-vivo gamma camera/8-slice CT technique: Case­control study of feline hyperthyroidism. Journal of Mechanics in Medicine and Biology, 2018; 18(8):1840035 https:// doi.org/10.1142/S0219519418400353

[29] Bartlett DL, Carr BI, Marsh JW. Cancer of the liver. In DeVita VT, Hellman S, Rosenberg SA, editor: Cancer: Principles and Practice of Oncology, Philadelphia, 2005, Lippincott Williams & Wilkins.

[30] McEntee MC. A survey of veterinary radiation facilities in the United States during 2001. Vet Radiol Ultrasound. 2004; 45:476-479. [PubMed: 15487574]

[31] Farrelly J, McEntee MC. A survey of veterinary radiation facilities in 2010. Vet Radiol Ultrasound. 2014; 55:638­643. [PubMed: 24798372]

[32] Xie HS, Lindsey W, Cheryl LC, et al., Practical Guide to Traditional Chinese Veterinary Medicine, Vol. 2: Small Animal Practice, August 1st, 2014, EdS, DACVIM-Neurology

[33] Patnaik AK, Lieberman PH, Erlandson RA, et al. Hepatobiliary neuroendocrine carcinoma

in cats: a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases. Vet Pathol. 2005; 42:331-337.

[34] Patnaik AK, Newman SJ, Scase T, et al. Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study. Vet Pathol. 2005; 42:140-146.

[35] Xie HS, Preast V, Xie's Veterinary Acupuncture, 1^st Edition, Blackwell Publishing, 2017, ISBN-13: 978-0813812472